CRISPR Therapeutics Stock (NASDAQ: CRSP) stock price, news, charts, stock research, profile.
Open | $55.53 |
Close | $54.01 |
Volume / Avg. | 1.31M / 1.35M |
Day Range | 53.33 - 55.69 |
52 Wk Range | 37.55 - 91.10 |
Market Cap | $4.60B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 40 |
Short Interest | 19.86% |
Days to Cover | 10.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.
There are no as such competitors for CRISPR Therapeutics.
There is no analysis for CRISPR Therapeutics.
CRISPR Therapeutics has a consensus price target of $69.21.
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $54.14 last updated June 28, 2024 at 6:50 PM EDT.
There are no upcoming dividends for CRISPR Therapeutics.
CRISPR Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for CRISPR Therapeutics.
CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.